Panel Discussion: Future Directions in Tolerizing Therapies
Time: 3:30 pm
day: Custom Day Two
Details:
• Creating a convincing preclinical data package to ignite regulatory excitement and push more ASIT therapies toward the clinic
• Strategies for determining clinical endpoints by phase of development – are surrogate endpoints the way forward?
• Assessing optimal modalities and disease areas for future development – are cell therapies the future of ASIT? Will
modulating the microbiome for IBD and Colitis be the next therapeutic area to tackle with ASIT therapies?
